Zenas BioPharma, Inc. (ZBIO) Reports Q3 Loss of $1.22
Tweet
Share
E-mailGet Alerts ZBIO Hot Sheet
Join SI Premium – FREE
Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q3 EPS of ($1.22).
For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Healthcare Triangle reports revenue of $9.19M in Q2 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
